SoniVie announces enrollment completion in the REDUCED-1 pilot study with TIVUS™ Ultra-Sound Renal Denervation
SoniVie announces enrollment completion in the REDUCED-1 pilot study
TEL AVIV, Israel, Feb. 1, 2024 /PRNewswire/ — SoniVie, an Israeli company developing a novel, proprietary Therapeutic Intra-Vascular Ultrasound (TIVUST… อ่านเพิ่ม